ICON plc - Ordinary Shares (NQ:ICLR)

162.05 UNCHANGED

Delayed Quote Updated: 4:00 PM EDT, Oct 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ICON plc - Ordinary Shares

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Examining the Future: Icon's Earnings Outlook ↗

October 21, 2025

Via Benzinga

What Analysts Are Saying About Icon Stock ↗

October 02, 2025

Via Benzinga

ICON PLC (NASDAQ:ICLR): A Value Investing Case Study ↗

September 29, 2025

ICON PLC (ICLR) presents a strong value investing case with attractive P/E ratios, solid profitability, and stable financial health, suggesting potential undervaluation.

Via Chartmill

ICON plc Schedules Third Quarter 2025 Earnings Conference Call

September 24, 2025

From ICON plc

Via Business Wire

11 Analysts Assess Icon: What You Need To Know ↗

September 09, 2025

Via Benzinga

Earnings Scheduled For July 23, 2025 ↗

July 23, 2025

Via Benzinga

Insights Ahead: Icon's Quarterly Earnings ↗

July 22, 2025

Via Benzinga

ICON Announces CEO Transition

September 04, 2025

From ICON plc

Via Business Wire

ICON plc to Participate at Upcoming Investor Conferences

September 02, 2025

From ICON plc

Via Business Wire

3 Healthcare Pathbreakers With Long-Term Tailwinds ↗

September 01, 2025

These three firms in the fast-changing healthcare sector stand out to analysts for their strong product lineups, defensible technology, and notable pipelines.

Via MarketBeat

Assessing Icon: Insights From 8 Financial Analysts ↗

August 21, 2025

Via Benzinga

ICON PLC (NASDAQ:ICLR) Presents a Compelling Value Investment Opportunity with Strong Fundamentals ↗

August 16, 2025

ICON PLC (ICLR) is a value stock with strong valuation metrics, solid profitability, and stable financials, trading below industry averages. A potential undervalued opportunity for investors.

Via Chartmill

Thermo Fisher, Baker Hughes And IQVIA Holdings Are Among Top 10 Large Cap Gainers Last Week (July 21-July 25): Are The Others In Your Portfolio? ↗

July 27, 2025

Medpace, ICON, and West Pharma led last week's large-cap rally, driven by strong earnings beats and upgraded guidance.

Via Benzinga

Topics Earnings

ICON Stock Up After Q2 Results Signal Growing Confidence In Biopharma Recovery ↗

July 24, 2025

ICON lifts its 2025 revenue forecast, beats booking targets in Q2 and expands its share buyback plan as market conditions remain variable.

Via Benzinga

RPM International Posts Better-Than-Expected Earnings, Joins ICON, MaxLinear, Nasdaq And Other Big Stocks Moving Higher On Thursday ↗

July 24, 2025

Via Benzinga

Thursday's session: gap up and gap down stocks ↗

July 24, 2025

Today's session on Thursday is marked by notable gaps in various stocks. Stay informed with the gap up and gap down stocks in today's session.

Via Chartmill

This Spotify Analyst Turns Bullish; Here Are Top 5 Upgrades For Thursday ↗

July 24, 2025

Via Benzinga

Why Alphabet Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket ↗

July 24, 2025

Via Benzinga

ICON PLC (NASDAQ:ICLR) Reports Q2 2025 Earnings Slightly Below Estimates, Shares Surge 13.76% in After-Hours Trading ↗

July 23, 2025

ICON PLC (ICLR) reported Q2 2025 earnings slightly below estimates but saw a 13.76% stock surge. Revenue hit $2.02B, EPS $3.26. AGM resolutions passed, boosting investor confidence.

Via Chartmill

Wednesday's after hours session: top gainers and losers ↗

July 23, 2025

After the conclusion of the US market's regular session on Wednesday, let's examine the after-hours session and unveil the notable performers among the top gainers and losers.

Via Chartmill

ICON Announces Results of Annual General Meeting

July 23, 2025

From ICON plc

Via Business Wire

ICON Reports Second Quarter 2025 Results

July 23, 2025

From ICON plc

Via Business Wire

D.R. Horton, IQVIA Holdings, Northrop Grumman And Other Big Stocks Moving Higher On Tuesday ↗

July 22, 2025

Via Benzinga

ICON’s Leadership and Performance in Phase 1 Clinical Trials Recognised in Independent Industry Benchmarking Report

July 16, 2025

From ICON plc

Via Business Wire

ICON PLC (NASDAQ:ICLR) – A Potentially Undervalued Stock in the Life Sciences Sector ↗

July 15, 2025

ICON PLC (NASDAQ:ICLR) appears undervalued with strong profitability and reasonable financial health, making it a potential candidate for value investors in the life sciences sector.

Via Chartmill

LVM Capital Management Dumps 16,000 ICON Public Shares Worth $2.6 million ↗

July 08, 2025

Via The Motley Fool

Topics Regulatory Compliance

ICON and Its Employees Recognised as Clinical Research Industry Leaders, and for Innovation and Progress in Sustainability

July 07, 2025

From ICON plc

Via Business Wire

ICON plc Schedules Second Quarter 2025 Earnings Conference Call

June 23, 2025

From ICON plc

Via Business Wire

ICLR Investors Have Opportunity to Lead ICON Public Limited Company Securities Fraud Lawsuit with the Schall Law Firm

June 02, 2025

From The Schall Law Firm

Via Business Wire

ICON plc to Present at the William Blair 45th Annual Growth Stock Conference

May 27, 2025

From ICON plc

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

12 13 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io. Quotes delayed at least 20 minutes. Market data may be delayed. Research information, not personalized advice.